1. Home
  2. BIAF vs ABTS Comparison

BIAF vs ABTS Comparison

Compare BIAF & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • ABTS
  • Stock Information
  • Founded
  • BIAF 2014
  • ABTS 2010
  • Country
  • BIAF United States
  • ABTS Hong Kong
  • Employees
  • BIAF N/A
  • ABTS N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • BIAF Health Care
  • ABTS Technology
  • Exchange
  • BIAF Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • BIAF 12.2M
  • ABTS 9.8M
  • IPO Year
  • BIAF 2022
  • ABTS N/A
  • Fundamental
  • Price
  • BIAF $0.23
  • ABTS $4.21
  • Analyst Decision
  • BIAF Hold
  • ABTS
  • Analyst Count
  • BIAF 1
  • ABTS 0
  • Target Price
  • BIAF N/A
  • ABTS N/A
  • AVG Volume (30 Days)
  • BIAF 706.3K
  • ABTS 16.7K
  • Earning Date
  • BIAF 08-14-2025
  • ABTS 08-13-2025
  • Dividend Yield
  • BIAF N/A
  • ABTS N/A
  • EPS Growth
  • BIAF N/A
  • ABTS N/A
  • EPS
  • BIAF N/A
  • ABTS N/A
  • Revenue
  • BIAF $7,681,059.00
  • ABTS $7,037,156.00
  • Revenue This Year
  • BIAF N/A
  • ABTS N/A
  • Revenue Next Year
  • BIAF $20.00
  • ABTS N/A
  • P/E Ratio
  • BIAF N/A
  • ABTS N/A
  • Revenue Growth
  • BIAF 4.99
  • ABTS 31.69
  • 52 Week Low
  • BIAF $0.16
  • ABTS $1.35
  • 52 Week High
  • BIAF $2.26
  • ABTS $14.10
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 32.85
  • ABTS 49.33
  • Support Level
  • BIAF $0.27
  • ABTS $3.87
  • Resistance Level
  • BIAF $0.30
  • ABTS $4.44
  • Average True Range (ATR)
  • BIAF 0.02
  • ABTS 0.33
  • MACD
  • BIAF -0.01
  • ABTS 0.00
  • Stochastic Oscillator
  • BIAF 2.58
  • ABTS 65.74

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.

Share on Social Networks: